Neumora Therapeutics Inc (NMRA)

Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten

Neumora Therapeutics patents new CKI-δ inhibitors - BioWorld Online

BioWorld Online

What was Neumora Therapeutics Inc. (NMRA)'s performance in the last session? – US Post News - US Post News

US Post News

Financial Metrics Exploration: Understanding Neumora Therapeutics Inc. (NMRA) Through Ratios – DWinneX - The Dwinnex

The Dwinnex

Neumora Therapeutics Inc. (NMRA) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News

SETE News

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 5.8% - Defense World

Defense World

Neumora Therapeutics (NASDAQ:NMRA) Shares Up 5.8% - MarketBeat

MarketBeat

Neumora Therapeutics (NASDAQ:NMRA) Reaches New 52-Week Low at $8.81 - MarketBeat

MarketBeat

Neumora Therapeutics Inc. (NMRA)'s stock price in review: A technical analysis – US Post News - US Post News

US Post News

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation

GlobeNewswire Inc.

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely - Simply Wall St

Simply Wall St

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely - Simply Wall St

Simply Wall St

RBC maintains $29 target on Neumora stock amid MDD study optimism - Investing.com South Africa

Investing.com South Africa

RBC maintains $29 target on Neumora stock amid MDD study optimism By Investing.com - Investing.com

Investing.com

RBC maintains $29 target on Neumora stock amid MDD study optimism - Investing.com UK

Investing.com UK

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

MarketBeat

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Defense World

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up to $10.00 - Defense World

Defense World

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up to $10.00 - MarketBeat

MarketBeat

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up to $10.00 - MarketBeat

MarketBeat

Gaining Ground: Neumora Therapeutics Inc. (NMRA) Closes Lower at 9.89, Down -5.09 – DWinneX - The Dwinnex

The Dwinnex

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Purchased by Avidity Partners Management LP - MarketBeat

MarketBeat

Neumora Therapeutics (NASDAQ:NMRA) Shares Down 5.7% - MarketBeat

MarketBeat

Neumora Therapeutics (NASDAQ:NMRA) Shares Down 5.7% - MarketBeat

MarketBeat

Neumora Therapeutics Inc. (NMRA)'s Ratio Roundup: Key Metrics for Trailing Twelve Months – DWinneX - The Dwinnex

The Dwinnex

Why Neumora Therapeutics (NMRA) Stock Might be a Great Pick - MSN

MSN

Analyzing Neumora Therapeutics Inc. (NMRA) After Recent Trading Activity – Knox Daily - Knox Daily

Knox Daily

Was Neumora Therapeutics Inc. (NMRA)'s session last reading good? – US Post News - US Post News

US Post News

Neumora Therapeutics Inc. (NMRA) Stock: From Low to High in 52 Weeks - The InvestChronicle

The InvestChronicle

Amalgamated Bank Makes New $29000 Investment in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Defense World

Neumora Therapeutics Enters Oversold Territory (NMRA) - Nasdaq

Nasdaq

Market Watch: Neumora Therapeutics Inc. (NMRA)'s Noteworthy Drop, Closing at 9.31 – DWinneX - The Dwinnex

The Dwinnex

A stock that deserves closer examination: Neumora Therapeutics Inc. (NMRA) – US Post News - US Post News

US Post News

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

MarketBeat

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

MarketBeat

This Neumora Therapeutics Insider Increased Their Holding In The Last Year - Yahoo Finance

Yahoo Finance

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Recommendation of “Moderate Buy” from ... - Defense World

Defense World

This Neumora Therapeutics Insider Increased Their Holding In The Last Year - Yahoo Finance

Yahoo Finance

6900 Shares in Neumora Therapeutics, Inc. (NASDAQ:NMRA) Purchased by New York State Common Retirement Fund - Defense World

Defense World

Investors in cash trouble should check out Neumora Therapeutics Inc. (NMRA) – Sete News - SETE News

SETE News

Stock Market Recap: Neumora Therapeutics Inc. (NMRA) Concludes at 9.58, a 6.92 Surge/Decline – DWinneX - The Dwinnex

The Dwinnex

Neumora launches phase 2 trial for bipolar depression treatment - Investing.com Canada

Investing.com Canada

Neumora launches phase 2 trial for bipolar depression treatment - Investing.com

Investing.com

Neumora launches phase 2 trial for bipolar depression treatment - Investing.com India

Investing.com India

Neumora launches phase 2 trial for bipolar depression treatment - Investing.com UK

Investing.com UK

NMRA (Neumora Therapeutics Inc.) has impressive results – US Post News - US Post News

US Post News

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression - ForexTV.com

ForexTV.com

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

GlobeNewswire Inc.

A Guide To The Risks Of Investing In Neumora Therapeutics Inc. (NMRA) – Knox Daily - Knox Daily

Knox Daily

Neumora launches phase 2 trial for bipolar depression treatment - Investing.com

Investing.com

Q3 2024 Earnings Estimate for Neumora Therapeutics, Inc. (NASDAQ:NMRA) Issued By William Blair - Defense World

Defense World